Clinical Trial: The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in Helicobacter Pylori Patients
Brief Summary: This study assessed the effect of tailored eradication therapy according to Clarithromycin resistance in Helicobacter pylori patients.
Detailed Summary:
This study assessed the effect of tailored eradication therapy according to Clarithromycin resistance in Helicobacter pylori patients.
The patients with gastric or duodenal ulcer by endoscopy were registered at the study and inspected Rapid Urease test, Biopsy, IgG-Hp antibody.
The tailored eradication therapy was prescribed to patients that confirmed Helicobacter pylori positive in two or more of among the three tests for 14 days. Through this, This study is to assess the effectiveness of eradication rate and to evaluate safety and tolerability of Ilaprazole 10mg qid treatment
Sponsor: Kyungpook National University
Current Primary Outcome: Eradication rate after tailored therapy assessed by urea breath test [ Time Frame: Test at 4 -6 weeks after completion of medication ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Number of participants with treatment-related adverse events as assessed by questionnaire [ Time Frame: Questionnaire and diary during medication for 14days ]
Original Secondary Outcome: Same as current
Information By: Kyungpook National University
Dates:
Date Received: January 5, 2016
Date Started: March 2, 2016
Date Completion:
Last Updated: February 19, 2017
Last Verified: February 2017